The Netherlands Authority for Consumers and Markets (ACM) has cleared the acquisition of the Dutch activities of veal company Van Dam by rival company Van Drie Group. Following an extensive investigation into the acquisition, ACM has determined that it is not likely that the acquisition will lead to lower purchase prices of calves or to foreclosure of competitors.
The Van Drie Group is active in the entire production chain in the veal sector. Van Drie’s main activities include the production of feed for calves, buying of young calves, calf husbandry, calf slaughterhouses, and the selling (export) of veal. The Van Drie Group is the market leader in the veal sector. Van Dam’s main activities include buying and selling calves, and calf husbandry.
ACM has assessed whether, after the acquisition, the leading market position of the Van Drie Group could result in a restriction of competition with adverse consequences. ACM has assessed whether, as a result of the acquisition, the Van Drie Group could lower the purchase prices it pays to dairy farmers and traders for their young calves. Lower prices can, particularly in the long term, lead to fewer investments in, for example, sustainability and animal welfare.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI